GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Stock
Total 13F shares: 0
Share change: -66
Total reported value: $0
Number of holders: 0
Value change: -$1,696
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 14888D208:

Q2 2025 Q1 2025 Q4 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

There are no holders of CBIO - GYRE THERAPEUTICS INC COM - Stock as of Q1 2024.